FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361766114> ?p ?o ?g. }

• W4361766114 endingPage "e37306" @default.
• W4361766114 startingPage "e37306" @default.
• W4361766114 abstract "Background Dengue fever can progress to dengue hemorrhagic fever (DHF), a more serious and occasionally fatal form of the disease. Indicators of serious disease arise about the time the fever begins to reduce (typically 3 to 7 days following symptom onset). There are currently no effective antivirals available. Drug repurposing is an emerging drug discovery process for rapidly developing effective DHF therapies. Through network pharmacology modeling, several US Food and Drug Administration (FDA)-approved medications have already been researched for various viral outbreaks. Objective We aimed to identify potentially repurposable drugs for DHF among existing FDA-approved drugs for viral attacks, symptoms of viral fevers, and DHF. Methods Using target identification databases (GeneCards and DrugBank), we identified human–DHF virus interacting genes and drug targets against these genes. We determined hub genes and potential drugs with a network-based analysis. We performed functional enrichment and network analyses to identify pathways, protein-protein interactions, tissues where the gene expression was high, and disease-gene associations. Results Analyzing virus-host interactions and therapeutic targets in the human genome network revealed 45 repurposable medicines. Hub network analysis of host-virus-drug associations suggested that aspirin, captopril, and rilonacept might efficiently treat DHF. Gene enrichment analysis supported these findings. According to a Mayo Clinic report, using aspirin in the treatment of dengue fever may increase the risk of bleeding complications, but several studies from around the world suggest that thrombosis is associated with DHF. The human interactome contains the genes prostaglandin-endoperoxide synthase 2 (PTGS2), angiotensin converting enzyme (ACE), and coagulation factor II, thrombin (F2), which have been documented to have a role in the pathogenesis of disease progression in DHF, and our analysis of most of the drugs targeting these genes showed that the hub gene module (human-virus-drug) was highly enriched in tissues associated with the immune system (P=7.29 × 10–24) and human umbilical vein endothelial cells (P=1.83 × 10–20); this group of tissues acts as an anticoagulant barrier between the vessel walls and blood. Kegg analysis showed an association with genes linked to cancer (P=1.13 × 10–14) and the advanced glycation end products–receptor for advanced glycation end products signaling pathway in diabetic complications (P=3.52 × 10–14), which indicates that DHF patients with diabetes and cancer are at risk of higher pathogenicity. Thus, gene-targeting medications may play a significant part in limiting or worsening the condition of DHF patients. Conclusions Aspirin is not usually prescribed for dengue fever because of bleeding complications, but it has been reported that using aspirin in lower doses is beneficial in the management of diseases with thrombosis. Drug repurposing is an emerging field in which clinical validation and dosage identification are required before the drug is prescribed. Further retrospective and collaborative international trials are essential for understanding the pathogenesis of this condition." @default.
• W4361766114 created "2023-04-04" @default.
• W4361766114 creator A5012601028 @default.
• W4361766114 creator A5054551173 @default.
• W4361766114 creator A5056522765 @default.
• W4361766114 creator A5062040751 @default.
• W4361766114 creator A5072270951 @default.
• W4361766114 creator A5088654357 @default.
• W4361766114 date "2023-05-09" @default.
• W4361766114 modified "2023-10-18" @default.
• W4361766114 title "The Identification of Potential Drugs for Dengue Hemorrhagic Fever: Network-Based Drug Reprofiling Study" @default.
• W4361766114 cites W1973576889 @default.
• W4361766114 cites W1983907306 @default.
• W4361766114 cites W2039396151 @default.
• W4361766114 cites W2077923150 @default.
• W4361766114 cites W2078414627 @default.
• W4361766114 cites W2097852545 @default.
• W4361766114 cites W2130691051 @default.
• W4361766114 cites W2159675211 @default.
• W4361766114 cites W2170146596 @default.
• W4361766114 cites W2474747771 @default.
• W4361766114 cites W2477204122 @default.
• W4361766114 cites W2501497123 @default.
• W4361766114 cites W2602102858 @default.
• W4361766114 cites W2743857398 @default.
• W4361766114 cites W2766967608 @default.
• W4361766114 cites W2767711842 @default.
• W4361766114 cites W2808004873 @default.
• W4361766114 cites W2906036013 @default.
• W4361766114 cites W2950420258 @default.
• W4361766114 cites W2988387420 @default.
• W4361766114 cites W3011072970 @default.
• W4361766114 cites W3027974486 @default.
• W4361766114 cites W3045028305 @default.
• W4361766114 cites W3085022707 @default.
• W4361766114 cites W3087136699 @default.
• W4361766114 cites W3107503376 @default.
• W4361766114 cites W3127311830 @default.
• W4361766114 cites W3145969289 @default.
• W4361766114 cites W3210331473 @default.
• W4361766114 doi "https://doi.org/10.2196/37306" @default.
• W4361766114 hasPublicationYear "2023" @default.
• W4361766114 type Work @default.
• W4361766114 citedByCount "0" @default.
• W4361766114 crossrefType "journal-article" @default.
• W4361766114 hasAuthorship W4361766114A5012601028 @default.
• W4361766114 hasAuthorship W4361766114A5054551173 @default.
• W4361766114 hasAuthorship W4361766114A5056522765 @default.
• W4361766114 hasAuthorship W4361766114A5062040751 @default.
• W4361766114 hasAuthorship W4361766114A5072270951 @default.
• W4361766114 hasAuthorship W4361766114A5088654357 @default.
• W4361766114 hasBestOaLocation W43617661141 @default.
• W4361766114 hasConcept C103637391 @default.
• W4361766114 hasConcept C126322002 @default.
• W4361766114 hasConcept C155261790 @default.
• W4361766114 hasConcept C159047783 @default.
• W4361766114 hasConcept C2777494893 @default.
• W4361766114 hasConcept C2779134260 @default.
• W4361766114 hasConcept C2779635636 @default.
• W4361766114 hasConcept C2780035454 @default.
• W4361766114 hasConcept C524204448 @default.
• W4361766114 hasConcept C533803919 @default.
• W4361766114 hasConcept C71924100 @default.
• W4361766114 hasConcept C98274493 @default.
• W4361766114 hasConceptScore W4361766114C103637391 @default.
• W4361766114 hasConceptScore W4361766114C126322002 @default.
• W4361766114 hasConceptScore W4361766114C155261790 @default.
• W4361766114 hasConceptScore W4361766114C159047783 @default.
• W4361766114 hasConceptScore W4361766114C2777494893 @default.
• W4361766114 hasConceptScore W4361766114C2779134260 @default.
• W4361766114 hasConceptScore W4361766114C2779635636 @default.
• W4361766114 hasConceptScore W4361766114C2780035454 @default.
• W4361766114 hasConceptScore W4361766114C524204448 @default.
• W4361766114 hasConceptScore W4361766114C533803919 @default.
• W4361766114 hasConceptScore W4361766114C71924100 @default.
• W4361766114 hasConceptScore W4361766114C98274493 @default.
• W4361766114 hasLocation W43617661141 @default.
• W4361766114 hasOpenAccess W4361766114 @default.
• W4361766114 hasPrimaryLocation W43617661141 @default.
• W4361766114 hasRelatedWork W1995517874 @default.
• W4361766114 hasRelatedWork W2008026220 @default.
• W4361766114 hasRelatedWork W2023274598 @default.
• W4361766114 hasRelatedWork W2051134904 @default.
• W4361766114 hasRelatedWork W2083004655 @default.
• W4361766114 hasRelatedWork W2096105915 @default.
• W4361766114 hasRelatedWork W2186465316 @default.
• W4361766114 hasRelatedWork W2308586264 @default.
• W4361766114 hasRelatedWork W3098921675 @default.
• W4361766114 hasRelatedWork W3213709983 @default.
• W4361766114 hasVolume "4" @default.
• W4361766114 isParatext "false" @default.
• W4361766114 isRetracted "false" @default.
• W4361766114 workType "article" @default.